Staring at the precipice of a different outcome, the world's wealthiest nations typically contribute roughly $122 billion annually to meet the long-term health, economic development, and welfare needs of low-income countries. However, this is not a typical year. The crises we face - Covid-19, the war in Ukraine, food shortages, inflation - have multiplied. Some nations are considering shifting their aid to humanitarian relief, such as housing Ukrainian refugees. The fight against diseases in low-income countries may cost billions.
We cannot ignore the suffering caused by war, but we cannot justify extreme suffering in one part of the world to alleviate it in another. While addressing the urgent needs of the world may be challenging, we cannot afford to overlook it. During the financial crisis, political will was shown to prioritize global health. Now, nations and organizations capable of providing aid should be compelled, in their next budgets, to donate more rather than less to healthcare initiatives.
Development aid constitutes only a small part of the budgets of donor nations, but it has been transformative for those who accept it. Over the past two decades, these contributions have helped the world experience one of its most significant progress periods in global health history. The child mortality rate for children under five dropped by over 50%, while deaths from some of the world's most dangerous infectious diseases fell by 46%. Economies grew too.
However, with Covid-19, things took a turn for the worse. The number of deaths from malaria and tuberculosis - preventable diseases that primarily affect low-income countries - is on the rise. Vaccination rates for children are declining.
We have the opportunity to return to course by investing in initiatives that we know will yield good returns. For example, consider the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Every $100 million invested in this fund leads to tuberculosis treatment for nearly 100,000 individuals, HIV counseling and testing for 4.3 million, and distribution of 7.6 million mosquito nets for malaria prevention, among other benefits.
Generous development aid can also accelerate promising breakthroughs. If funds for distribution are available, a new oral polio vaccine might help finally eradicate polio. A much-promised antiretroviral drug, once prohibitively expensive, is now widely available and reduces the risk of death from AIDS.
Ending the sorrow of a parent burying their child is a justification enough to invest. But smart investments can achieve even more. Eliminating preventable diseases can help families and entire countries escape poverty and find stability. Donor nations have the opportunity to save money while improving healthcare through their contributions to global health efforts: spend $100 million on the Global Fund, and generate a nearly $3 billion return.
These investments can help prevent a viral threat in one part of the world from spreading and causing harm in another. The consequences of this pandemic may be devastating, but they could be far worse. Innovations and systems that prevent and treat diseases in normal times take on decisive importance during crises.
Pakistan has built a strong polio surveillance and rapid response infrastructure that has also proven useful in the fight against Covid-19. In South Africa, the Genomic Surveillance Network was developed to track epidemics like Ebola, yellow fever, and other diseases, allowing scientists to identify new coronavirus variants. Pakistan's robust healthcare system, developed in response to HIV, enabled a swift response to COVID-19.
Everyone has a role to play in contributing to this healthier and fairer future. Developing and global institutions, like the G7, must prioritize the needs of low-income countries. They might even direct the International Monetary Fund to redistribute financial assets, such as recently allocated special drawing rights, to alleviate the burden of Covid-19 and give all nations an equal chance at recovery.
and are keeping you updated on the latest opinions, analyses, and discussions on social media. We welcome your ideas and comments.
Philanthropic foundations should increase their funding for global health initiatives, focusing on the countries that need it most. Pharmaceutical companies can sell drugs at lower costs in low-income countries and engage in more second-source deals, allowing other countries to produce drugs in times of critical need. Large corporations can increase their contributions to humanitarian efforts and multilateral global health organizations.
Countries facing daily challenges can further strengthen their healthcare systems, knowing that they will make a difference. Now more than ever, we have the power to create a world that didn't exist at your birth. Whether you live or die depends on our bold commitments. If we make these commitments now, we can achieve a healthier and fairer future for all.
The risk of Covid-19 spreading in countries with limited resources would shrink with less investment in healthcare. Many countries are understandably concerned that their public finances do not have sufficient reserves to prepare for an outbreak of the disease.
Support in the form of money or medicine donations can help low-income countries protect their populations from outbreaks of epidemic diseases like Covid-19. In this sense, even minor opinions or public statements supporting development aid may play a crucial role in influencing political decisions and strengthening the responsibility of wealthy countries to aid low-income countries.
Source:
Strategies for Rich Countries to Enhance Global Health Efforts:
- Increase Bilateral and Multilateral Funding:
- Bilateral Programs: Most U.S. global health funding is provided bilaterally, directly funding the implementation of global health activities in partnership countries. Increasing this funding can significantly support low-income countries in addressing health crises.
- Multilateral Organizations: Contributing to multilateral organizations like the Global Fund to Fight AIDS, Tuberculosis, and Malaria (Global Fund) can leverage resources and expertise to combat infectious diseases effectively.
- Targeted Investments:
- Noncommunicable Diseases (NCDs): Focusing on reducing major risk factors for NCDs, like tobacco use, physical inactivity, and unhealthy diets, can significantly reduce premature deaths in low-income countries.
- Infectious Diseases: Investing in programs to control infectious diseases like HIV, TB, and malaria is crucial. The Global Fund’s efforts have shown that sustained investment can reduce mortality from these diseases by 64% and save millions of lives.
- Strengthening Health Systems:
- Universal Health Coverage (UHC): Ensuring that everyone has access to quality health services without financial hardship is essential. Developed countries can support low-income countries in achieving UHC by providing financial risk protection and access to essential health care services.
- Research and Development:
- Vaccine Development: Supporting research and development of vaccines and medicines for communicable and noncommunicable diseases can provide affordable essential medicines and vaccines, especially for developing countries.
- Capacity Building:
- Health Workforce Development: Strengthening the capacity of low-income countries by recruiting, developing, training, and retaining health workers is critical for effective disease management and prevention.
- Coordination and Collaboration:
- WHO’s Role: The World Health Organization (WHO) plays a crucial role in coordinating global responses to public health threats. Developed countries can support WHO’s efforts in surveillance, prevention, and control of diseases, as well as in providing technical assistance and training to low-income countries.
- Sustainable Funding Models:
- Long-term Planning: Supporting long-term planning in low-income countries can help them scale new technologies and service delivery, making their health systems more resilient against future pandemics and health emergencies.
